Sleep Quality and Risk of Perinatal Depression
Sleep disturbance is commonly reported during pregnancy. A recent study looked at the impact of sleep quality on risk for depression.
Sleep disturbance is commonly reported during pregnancy. A recent study looked at the impact of sleep quality on risk for depression.
A recent study examines the relationship between postpartum depression (PPD) and cigarette smoking. The study sample consisted of 29,654 U.S. women who reported smoking in the 3 months prior to pregnancy and for whom data on PPD were available from the Pregnancy Risk Assessment Monitoring System (PRAMS).
Restless legs syndrome (RLS) occurs commonly during pregnancy and can sometimes casues significant sleep disturbance. A new study suggests that RLS may also increase the risk of perinatal depression.
Two recent reports explore the relationship between abuse and risk for perinatal depression. The first is a study which analyzed data from 53,065 pregnant women participating in the Norwegian Mother and Child Cohort Study (MoBa). [...]
About 10% to 15% of women experience clinically significant depressive symptoms during pregnancy. Furthermore, women with a history of major depression appear to be at high risk for recurrent illness during pregnancy particularly in the [...]
This is a relatively small study but I think it underscores the importance of screening for and treating depression during pregnancy. Previous studies have indicated that about 10% to 15% of women experience clinically significant [...]
While various studies have recently examined the prevalence of depression during pregnancy, few of these studies have examined how being an ethnic minority may influence the risk of antenatal depression. Â A new study from Oslo, Norway suggests that certain ethnic minorities may have a higher risk.
A recent study examined the prevalence and risk factors for perinatal depression and anxiety in a group of Norwegian women with epilepsy (n = 706) compared to pregnancies in all women without epilepsy (n = 106,511).
85 women with postpartum depression were randomized to receive acupuncture plus psychological intervention (five sessions per week) or treatment with fluoxetine (20 mg per day). The two groups were treated continuously for six weeks. Depressive symptoms were measured using the Hamilton Depression scale (HAMD).
Augmentation strategies can be used to optimize response in patients with major depressive disorder (MDD) who have not responded adequately to antidepressant monotherapy; however, we have no data on the use of adjunctive treatments in women with postpartum depression (PPD).  A recent study tested the effectiveness of antidepressant augmentation with aripiprazole (Abilify) in a cohort of 10 women with onset of a depression within 3 months of the birth of a healthy, close-to-term baby.